Literature DB >> 6235163

Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.

R A Heijtink, P De Jong, S W Schalm, N Masurel.   

Abstract

The immune response after vaccination with H-B-VAX (20 micrograms, Months 0, 1 and 6) was investigated in 23 Down's syndrome patients and compared to that in 30 other mentally retarded patients and 32 staff members. About 90% of Down's syndrome and other mentally retarded patients and 100% of staff members had anti-HBs at Month 9, but anti-HBs less than 10 IU per liter were found in 6/23 (26.1%) of Down's syndrome, 7/30 (23.3%) of other mentally retarded patients, in contrast to 2/32 (6.2%) of staff members. No differences in anti-HBs response with regard to sex and age were observed in staff members, but geometric mean titers of anti-HBs were lower in older Down's syndrome and other mentally retarded patients, and in male Down's syndrome patients. Supplementary vaccination is necessary in these individuals to obtain "protective levels" of anti-HBs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235163     DOI: 10.1002/hep.1840040406

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Hepatitis B and Down's syndrome.

Authors:  J Green
Journal:  BMJ       Date:  1988-11-19

2.  Prevalence of hepatitis B infection in long-stay mentally handicapped adults.

Authors:  F Asensio; J M Bayas; M J Bertran; M A Asenjo
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Prevalence of anti-HCV in institutionalised mentally handicapped subjects.

Authors:  F Pregliasco; A Conti
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

4.  Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.

Authors:  J Hayashi; A Noguchi; K Nakashima; M Morofuji; S Kashiwagi
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.